CD274 and neoplasm: This includes lower proportions of tumor-infiltrating lymphocytes (TILs), reduced expression of programmed death ligand 1 (PD-L1), decreased signals related to interferon γ and upregulation of anti-inflammatory markers TOLLIP and HLA-G.